Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 917150, 8 pages
http://dx.doi.org/10.1155/2014/917150
Review Article

Role of CT Perfusion in Monitoring and Prediction of Response to Therapy of Head and Neck Squamous Cell Carcinoma

1Division of Radiology, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20141 Milan, Italy
2University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy
3Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy

Received 20 May 2014; Accepted 5 July 2014; Published 21 July 2014

Academic Editor: Mazzei Maria Antonietta

Copyright © 2014 Lorenzo Preda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. S. van Monsjou, A. J. M. Balm, M. M. van den Brekel, and V. B. Wreesmann, “Oropharyngeal squamous cell carcinoma: a unique disease on the rise?” Oral Oncology, vol. 46, no. 11, pp. 780–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Forastiere, H. Goepfert, and M. Maor, “Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer,” The New England Journal of Medicine, vol. 349, pp. 2091–2098, 2003. View at Google Scholar · View at Scopus
  3. J. Ma, Y. Liu, X. Huang et al., “Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis,” Oral Oncology, vol. 48, no. 11, pp. 1076–1084, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Wirth and M. R. Posner, “Recent advances in combined modality therapy for locally advanced head and neck cancer,” Current Cancer Drug Targets, vol. 7, no. 7, pp. 674–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Vermorken, R. S. Herbst, X. Leon, N. Amellal, and J. Baselga, “Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies,” Cancer, vol. 112, no. 12, pp. 2710–2719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Bonner, P. M. Harari, J. Giralt et al., “Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck,” The New England Journal of Medicine, vol. 354, no. 6, pp. 567–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. Vermorken, E. Remenar, C. van Herpen et al., “Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer,” The New England Journal of Medicine, vol. 357, pp. 1695–1704, 2007. View at Publisher · View at Google Scholar
  8. M. T. Truong, N. Saito, A. Ozonoff et al., “Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy,” The American Journal of Neuroradiology, vol. 32, no. 7, pp. 1195–1201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Petralia, L. Preda, G. Giugliano et al., “Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: Correlation between changes in tumor perfusion and tumor volume,” Journal of Computer Assisted Tomography, vol. 33, no. 4, pp. 552–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Gandhi, D. B. Chepeha, T. Miller et al., “Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy,” American Journal of Neuroradiology, vol. 27, no. 1, pp. 101–106, 2006. View at Google Scholar · View at Scopus
  11. K. Š. Šurlan-Popovič, S. Bisdas, Z. Rumboldt, T. S. Koh, and P. Strojan, “Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy,” American Journal of Neuroradiology, vol. 31, no. 3, pp. 570–575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Hermans, M. Meijerink, W. van den Bogaert, A. Rijnders, C. Weltens, and P. Lambin, “Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 57, no. 5, pp. 1351–1356, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos, and S. K. Mukherji, “Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?” American Journal of Neuroradiology, vol. 28, no. 2, pp. 328–334, 2007. View at Google Scholar · View at Scopus
  14. S. Bisdas, Z. Rumboldt, J. Wagenblast et al., “Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements,” The American Journal of Neuroradiology, vol. 30, no. 4, pp. 793–799, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bisdas, S. A. Nguyen, S. K. Anand, G. Glavina, T. Day, and Z. Rumboldt, “Outcome prediction chemoradiation of in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume,” International Journal of Radiation Oncology* Biology* Physics, vol. 73, no. 5, pp. 1313–1318, 2009. View at Publisher · View at Google Scholar
  16. S. Bisdas, Z. Rumboldt, K. Surlan-Popovic et al., “Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements,” American Journal of Neuroradiology, vol. 31, no. 3, pp. 576–581, 2010. View at Google Scholar
  17. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar
  18. L. Preda, E. Lovati, F. Chiesa et al., “Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility,” European Radiology, vol. 17, no. 8, pp. 2096–2102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Hermans, K. Op de Beeck, W. van den Bogaert et al., “The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment,” International Journal of Radiation Oncology, Biology, Physics, vol. 50, no. 1, pp. 37–45, 2001. View at Google Scholar
  20. A. Srinivasan, S. Mohan, and S. K. Mukherji, “Biologic imaging of head and neck cancer: the present and the future,” American Journal of Neuroradiology, vol. 33, no. 4, pp. 586–594, 2012. View at Publisher · View at Google Scholar
  21. A. M. Tawfik, A. A. Razek, L. G. Elsorogy et al., “Perfusion CT of head and neck cancer,” European Journal of Radiology, vol. 83, no. 3, pp. 537–544, 2014. View at Google Scholar
  22. G. Petralia, L. Preda, G. D'Andrea et al., “CT perfusion in solid-body tumours. Part I: technical issues,” Radiologia Medica, vol. 115, no. 6, pp. 843–857, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Petralia, L. Bonello, S. Viotti, L. Preda, G. D'Andrea, and M. Bellomi, “CT perfusion in oncology: how to do it,” Cancer Imaging, vol. 10, no. 1, pp. 8–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Tawfik, A. A. Abdel Razek, L. G. Elsorogy et al., “Perfusion CT of head and neck cancer: effect of arterial input selection,” American Journal of Roentgenology, vol. 196, no. 6, pp. 1374–1380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Petralia, L. Preda, S. Raimondi et al., “Intra and interobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive tract,” The American Journal of Neuroradiology, vol. 30, no. 6, pp. 1107–1115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Miles, “Perfusion CT for the assessment of tumour vascularity: which protocol?” British Journal of Radiology, vol. 76, no. 1, pp. S36–S42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. R. Kambadakone and D. V. Sahani, “Body perfusion CT: technique, clinical applications, and advances,” Radiologic Clinics of North America, vol. 47, no. 1, pp. 161–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Goh, S. Halligan, A. Gharpuray, D. Wellsted, J. Sundin, and C. I. Bartram, “Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest,” Radiology, vol. 247, no. 3, pp. 726–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Bellomi, S. Viotti, L. Preda, G. D'Andrea, L. Bonello, and G. Petralia, “Perfusion CT in solid body-tumours. Part II: clinical applications and future development,” La Radiologia Medica, vol. 115, no. 6, pp. 858–874, 2010. View at Google Scholar
  30. V. K. Gupta, N. T. Jaskowiak, M. A. Beckett et al., “Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance,” Cancer Journal, vol. 8, no. 1, pp. 47–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Martone, P. Rosso, R. Albera et al., “Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome,” Oral Oncology, vol. 41, no. 2, pp. 147–155, 2005. View at Google Scholar
  32. K. P. Claffey, L. F. Brown, L. F. Del Aguila et al., “Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis,” Cancer Research, vol. 56, no. 1, pp. 172–181, 1996. View at Google Scholar · View at Scopus
  33. H. Axelson, E. Fredlund, M. Ovenberger, G. Landberg, and S. Påhlman, “Hypoxia-induced dedifferentiation of tumor cells–a mechanism behind heterogeneity and aggressiveness of solid tumors,” Seminars in Cell and Developmental Biology, vol. 16, no. 4-5, pp. 554–563, 2005. View at Google Scholar